HET-1A 人食管上皮细胞

HET-1A细胞系是1986年从人食管尸检组织中通过转染质粒pRSV-T获得的，该质粒由RSV-LTR启动子和编码猿猴病毒40大T抗原的序列组成。细胞已经过超250多次的传代倍增，生长因子研究表明，HET-1A受到钙的刺激，并受到胎牛血清、转化生长因子β1和转化生长因子β2的抑制。伏马菌素B1在HET-1A细胞中产生生长抑制和凋亡增加。合成维甲酸CD437（6-[3-（1-金刚基）-4-羟基苯基]-2-萘甲酸（AHPN/CD437）0通过caspase-3依赖途径诱导食管鳞状上皮HET-1A细胞凋亡，该细胞系可能有助于研究假定的食管致癌物的作用。

组织来源/Tissue and Cell Type ：食管

形态/Morphology ：上皮细胞样，贴壁生长

培养基和添加剂/Complete Growth Medium and Culture Conditions：

BEGM kit培养基  (Lonza/Clonetics，CC-3170)

气相：空气，95%；二氧化碳，5%。 温度：37摄氏度。

冻存条件：基础培养基+5%DMSO+20%FBS(SD0200)

完全冻存液：低血清免程序细胞冻存液（SD0001） 

注意事项：此产品仅供科研使用

CLPUB00265

Stoner G.D., Kaighn M.E., Resau J.H., Naito Z., Bowman D., Harris C.C.

Immortalized human esophageal epithelial cell lines for studies of carcinogen-induced cell transformation.

In Vitro Cell. Dev. Biol. 26:23A-23A(1990)

DOI=10.1007/978-1-4612-0411-4_30

Stoner G.D., Light B.A., Harris C.C.

Immortalization and oncogene transformation of human esophageal epithelial cells.

(In) Neoplastic transformation in human cell system. Mechanism of carcinogenesis; Rhim J.S., Dritschilo A. (eds.); pp.297-305; Humana Press; New York (1990)

Patent=WO1991005062A1

Stoner G.D., Reddel R.R., Harris C.C.

Human esophageal epithelial cell lines.

Patent number WO1991005062A1, 18-Apr-1991

PubMed=1703038

Stoner G.D., Kaighn M.E., Reddel R.R., Resau J.H., Bowman D., Naito Z., Matsukura N., You M., Galati A.J., Harris C.C.

Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells.

Cancer Res. 51:365-371(1991)

PubMed=8504475; DOI=10.1093/carcin/14.5.833

Lehman T.A., Modali R., Boukamp P., Stanek J., Bennett W.P., Welsh J.A., Metcalf R.A., Stampfer M.R., Fusenig N.E., Rogan E.M., Harris C.C.

p53 mutations in human immortalized epithelial cell lines.

Carcinogenesis 14:833-839(1993)

PubMed=7972006; DOI=10.1073/pnas.91.23.11045

Okamoto A., Demetrick D.J., Spillare E.A., Hagiwara K., Hussain S.P., Bennett W.P., Forrester K., Gerwin B., Serrano M., Beach D.H., Harris C.C.

Mutations and altered expression of p16INK4 in human cancer.

Proc. Natl. Acad. Sci. U.S.A. 91:11045-11049(1994)

PubMed=10078940; DOI=10.1002/(sici)1098-2744(199902)24:2

Compton K.R., Orringer M.B., Beer D.G.

Induction of glutathione s-transferase-pi in Barrett's metaplasia and Barrett's adenocarcinoma cell lines.

Mol. Carcinog. 24:128-136(1999)

PubMed=20139130; DOI=10.1093/carcin/bgq036

Duggan S.P., Behan F.M., Kirca M., Smith S.M., Reynolds J.V., Long A., Kelleher D.P.

An integrative genomic approach in oesophageal cells identifies TRB3 as a bile acid responsive gene, downregulated in Barrett's oesophagus, which regulates NF-kappaB activation and cytokine levels.

Carcinogenesis 31:936-945(2010)

PubMed=20843300; DOI=10.1042/BC20100071

Underwood T.J., Derouet M.F., White M.J., Noble F., Moutasim K.A., Smith E., Drew P.A., Thomas G.J., Primrose J.N., Blaydes J.P.

A comparison of primary oesophageal squamous epithelial cells with HET-1A in organotypic culture.

Biol. Cell 102:635-644(2010)

PubMed=21127259; DOI=10.1152/ajpgi.00461.2010

Goldman A., Chen H.D.R., Roesly H.B., Hill K.A., Tome M.E., Dvorak B., Bernstein H., Dvorak K.

Characterization of squamous esophageal cells resistant to bile acids at acidic pH: implication for Barrett's esophagus pathogenesis.

Am. J. Physiol. Gastrointest. Liver Physiol. 300:G292-G302(2011)

PubMed=28224081; DOI=10.1016/j.gdata.2017.02.002

Akagi I., Ishibashi O.

RNA-Seq analysis of human cell lines established from normal and neoplastic esophageal squamous epithelium.

Genomics Data 12:4-6(2017)